New approach methodologies for assessing developmental toxicity of pharmaceuticals: Case examples and future directions

发育毒性 生化工程 风险分析(工程) 毒性 计算生物学 计算机科学 业务 医学 生物 工程类 内科学 妊娠期 遗传学 怀孕
作者
Nicola Powles-Glover,Allen R. Kaczor,Steven J.M. Van Cruchten,Christopher Bowman,Kimberly C. Brannen,Claudia Demarta‐Gatsi,Isabelle LeConte,Amer Jamalpoor,Fumito Mikashima,Shermaine K. Mitchell-Ryan,Dinesh Stanislaus,Peter T. Theunissen,Belen M. Tornesi,Ronald L. Wange,Connie L. Chen
出处
期刊:Reproductive Toxicology [Elsevier BV]
卷期号:137: 109035-109035 被引量:13
标识
DOI:10.1016/j.reprotox.2025.109035
摘要

Several new approach methodologies (NAMs) for developmental toxicity (Dev Tox) testing are being used by pharmaceutical companies for derisking or for exploring Dev Tox mechanisms. Regulatory adoption of these NAMs-based approaches as being adequate for Dev Tox risk assessment has been more challenging, due, in part, to dynamic changes in the conceptus and placenta throughout development and the impact of the pharmaceutical on the mother's physiology, which may also have an embryo-fetal impact. Still, there is currently a recognition by Health Authorities that there are certain contexts-of-use under which Dev Tox NAMs can provide information that is adequate to inform risk. This has been adopted in the 3rd revision of the ICH S5 guideline, which provides a path to qualify Dev Tox NAMs for regulatory decision making. Despite this opportunity, pharmaceutical companies rarely submit Dev Tox NAMs to Health Authorities for qualification or with intent to support regulatory decision making. This may be in part due to the need for a greater understanding of the biological relationship between currently available Dev Tox NAMs and in vivo outcome, applicability domain, translatability, predictivity, and that these NAMs do not cover the complete scope of embryo-fetal development. Furthermore, there is a lack of Dev Tox NAMs data visibility to Health Authorities. To use Dev Tox NAMs for regulatory decision making, more data sharing with Health Authorities and further understanding the applicability domain of these methodologies are needed.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
光亮白山完成签到 ,获得积分10
刚刚
水煮电吹风的应助被yu采纳,获得10
刚刚
朴实白卉完成签到,获得积分10
1秒前
1秒前
老詹头发布了新的文献求助30
1秒前
深情的乐萱完成签到,获得积分10
1秒前
明理的帆布鞋完成签到,获得积分10
1秒前
2秒前
2秒前
Orange的应助被CKK采纳,获得10
2秒前
ZBA完成签到,获得积分10
2秒前
2秒前
QQ发布了新的文献求助10
2秒前
万能图书馆的应助被Len采纳,获得10
2秒前
3秒前
小管发布了新的文献求助10
3秒前
标致青雪发布了新的文献求助10
3秒前
ding的应助被lihua采纳,获得10
3秒前
4秒前
一艘小船发布了新的文献求助10
4秒前
4秒前
今后的应助被franklove采纳,获得10
4秒前
5秒前
5秒前
CloudStrife完成签到,获得积分10
5秒前
一眼顶针完成签到,获得积分10
6秒前
充电宝的应助被慕念采纳,获得10
6秒前
赤川川川完成签到 ,获得积分10
6秒前
沥练的应助被HH采纳,获得10
6秒前
xol完成签到 ,获得积分10
7秒前
sci菜鸟完成签到,获得积分10
7秒前
zz完成签到,获得积分10
7秒前
8秒前
8秒前
搜集达人的应助被顶刊相见采纳,获得30
8秒前
米米发布了新的文献求助10
8秒前
烟花的应助被星空采纳,获得10
8秒前
pc666完成签到,获得积分10
8秒前
zhilingZhang完成签到,获得积分10
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180488
求助须知:如何正确求助?哪些是违规求助? 9570485
关于积分的说明 21812623
捐赠科研通 7776592
什么是DOI,文献DOI怎么找? 3433286
关于科研通互助平台的介绍 2557522
邀请新用户注册赠送积分活动 2479162